康泰医学 (300869.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

现金流量表(康泰医学)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 754,050,044.78614,217,188.41370,742,430.27693,718,673.57489,260,746.50344,285,174.37181,460,133.04
 收到的税费返还(元) 44,811,594.4937,489,300.5821,166,344.3338,119,446.3233,238,811.3420,670,331.4610,987,403.87
 收到其他与经营活动有关的现金(元) 39,399,135.6730,277,098.9018,931,636.3465,100,440.9549,859,204.1135,653,329.3727,808,395.11
 经营活动现金流入小计(元) 838,260,774.94681,983,587.89410,840,410.94796,938,560.84572,358,761.95400,608,835.20220,255,932.02
 购买商品、接受劳务支付的现金(元) 331,401,121.30281,770,246.86173,980,394.69369,664,685.79295,448,239.74216,438,004.7698,823,713.78
 支付给职工以及为职工支付的现金(元) 159,560,029.46102,663,048.9559,520,945.56171,963,814.09114,109,140.1374,815,396.2642,830,540.37
 支付的各项税费(元) 68,622,374.8368,719,289.7130,802,977.6348,015,300.0249,369,516.7142,469,438.0928,975,073.97
 支付其他与经营活动有关的现金(元) 100,954,935.3771,925,480.5345,019,737.43103,637,908.6146,362,048.1830,078,028.6314,075,073.00
 经营活动现金流出小计(元) 660,538,460.96525,078,066.05309,324,055.31693,281,708.51505,288,944.76363,800,867.74184,704,401.12
 经营活动产生的现金流量净额(元) -156,905,521.84-103,656,852.33-36,807,967.46-
二、投资活动产生的现金流量
 取得投资收益收到的现金(元) 55,690,364.3354,656,030.9926,683,525.0522,056,345.391,699,866.471,671,999.84835,999.92
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 64,395.2464,395.24-253,499.38---
 收到其他与投资活动有关的现金(元) 66,000,000.0066,000,000.00-----
 投资活动现金流入小计(元) 121,754,759.57120,720,426.2326,683,525.0522,309,844.771,699,866.471,671,999.84835,999.92
 购建固定资产、无形资产和其他长期资产支付的现金(元) 38,773,729.3422,511,173.9016,077,337.5281,446,712.9360,205,874.6946,149,562.8228,298,746.97
 投资支付的现金(元) 650,000,000.00------
 支付其他与投资活动有关的现金(元) 150,000,000.00170,000,000.00170,000,000.0054,687,315.14---
 投资活动现金流出小计(元) 838,773,729.34192,511,173.90186,077,337.52136,134,028.0760,205,874.6946,149,562.8228,298,746.97
 投资活动产生的现金流量净额(元) -717,018,969.77-71,790,747.67-159,393,812.47-113,824,183.30-58,506,008.22-44,477,562.98-27,462,747.05
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) ----690,100,000.00--
 取得借款收到的现金(元) 632,878,400.00632,878,400.00210,000,000.00874,877,357.32794,877,357.32746,419,181.31413,853,595.00
 发行债券收到的现金(元) ---690,100,000.00---
 收到其他与筹资活动有关的现金(元) 119,493,200.44119,776,820.84112,376,199.40180,000,000.00192,483,513.89--
 筹资活动现金流入小计(元) 752,371,600.44752,655,220.84322,376,199.401,744,977,357.321,677,460,871.21746,419,181.31413,853,595.00
 偿还债务支付的现金(元) 976,810,125.90776,810,125.90430,474,085.00787,046,690.00708,579,290.00589,259,315.00382,728,975.00
 分配股利、利润或偿付利息支付的现金(元) 64,942,395.9557,536,805.171,801,231.87123,917,532.95122,914,429.55123,790,171.811,085,703.71
 支付其他与筹资活动有关的现金(元) 202,562,846.72204,224,746.43100,876,946.7052,675,229.0151,057,225.7351,991,374.0750,380,786.29
 筹资活动现金流出小计(元) 1,244,315,368.571,038,571,677.50533,152,263.57963,639,451.96882,550,945.28765,040,860.88434,195,465.00
 筹资活动产生的现金流量净额(元) -491,943,768.13-285,916,456.66-210,776,064.17781,337,905.36794,909,925.93-18,621,679.57-20,341,870.00
四、汇率变动对现金及现金等价物的影响(元) 6,881,813.017,322,803.218,989,326.2217,580,131.1311,705,953.031,388,162.8219,863,545.37
五、现金及现金等价物净增加额(元) -1,024,358,610.91-193,478,879.28-259,664,194.79788,750,705.52815,179,687.93-24,903,112.277,610,459.22
 加:期初现金及现金等价物余额(元) 1,387,323,098.061,387,323,098.061,387,323,098.06598,572,392.54598,572,392.54598,572,392.54598,572,392.54
 期末现金及现金等价物余额(元) 362,964,487.151,193,844,218.781,127,658,903.271,387,323,098.061,413,752,080.47573,669,280.27606,182,851.76
补充资料:
 净利润(元) -182,886,433.38-196,202,558.53-115,376,382.10-
 资产减值准备(元) -7,563,896.73-5,844,009.66-2,321,015.58-
 固定资产和投资性房地产折旧(元) -11,532,987.83-16,627,393.98-8,156,920.14-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) -10,765,933.13-15,093,284.58-7,389,865.42-
     投资性房地产折旧(元) -767,054.70-1,534,109.40-767,054.72-
 无形资产摊销(元) -1,192,576.65-2,336,332.08-1,142,729.64-
 递延收益摊销(元) --974,301.64--2,251,635.87--1,141,058.19-
 处置固定资产、无形资产和其他长期资产的损失(元) -5,635.27-259,786.22---
 固定资产报废损失(元) --11,408.15-11,408.15---
 公允价值变动损失(元) -46,629,765.37--46,636,450.30---
 财务费用(元) --2,844,869.75--44,605,540.37--49,773,001.26-
 投资损失(元) --56,072,275.43--7,958,625.00---
 递延所得税(元) --9,582,645.02-2,696,540.10--1,110,629.45-
  其中:递延所得税资产减少(元) -392,187.26--1,078,970.44--683,743.21-
 递延所得税负债增加(元) --9,974,832.28-3,775,510.54--426,886.24-
 存货的减少(元) --97,957,911.20--17,387,361.26--42,151,388.66-
 经营性应收项目的减少(元) -126,089,755.03--64,492,468.17-22,457,685.10-
 经营性应付项目的增加(元) --52,831,808.66-59,337,086.54--19,938,825.00-
 现金的期末余额(元) -1,193,844,218.78-1,387,323,098.06-573,669,280.27-
 减:现金的期初余额(元) -1,387,323,098.06-598,572,392.54-598,572,392.54-
 现金及现金等价物的净增加额(元) --193,478,879.28-788,750,705.52--24,903,112.27-
公告日期 2023-10-302023-08-302023-04-272023-04-272022-10-272022-08-272022-04-29
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院